fda glp-1 compounding warning letters september 2025 The has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers., "All of a sudden, you have FDA Drug Recalls and Warnings:

When exploring digital health programs or vendor partnerships, it is essential to critically evaluate clinical oversight, regulatory compliance, and outcomes reporting to ensure alignment with your organizations standards and member safety

This protocol is intended as educational guidance and should only be implemented by qualified healthcare providers operating within applicable regulatory frameworks

Standard practice uses 25-gauge 1-inch needles, but 27-gauge 1.25-inch needles reduce injection pain significantly while ensuring intramuscular (not subcutaneous) delivery in patients with body fat percentages above 25%

The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis